GSK wins FDA approval for first drug treating liver disease itch
Go back to GSK wins FDA approval for first drug treating liver disease itch| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.64 +0.90 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $51.63 | 52 Week Low | $37.82 | |||
| Day High | $52.05 | P/E | N/A | |||
| Day Low | $51.51 | EPS | $0.00 | |||
| Volume | 906,137 | |||||
